- Market cap
- Revenue
- Net income
- Cash on hand
- Gross margin
- Net margin
- EPS
- P/E ratio
Aardvark Therapeutics, Inc. (Aardvark), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today announced the appointments of Roy D. Baynes, M.D., Ph.D., and Susan E. Graf, RPh, MBA to its Board of Directors. Dr. Baynes was previously Chief Medical Officer and head […]
SAN DIEGO, Sept. 10, 2024 — Aardvark Therapeutics, Inc., a biopharmaceutical company, announced the appointment of Manasi Sinha Jaiman, M.D., M.P.H. as Chief Medical Officer and Tom Bicsak, Ph.D., as Head of Regulatory Affairs today.  Commenting on the new hires, Aardvark CEO Tien Lee, M.D. said, “These new key positions will significantly accelerate the development of our lead investigational asset, […]
Dr. Tien Lee, Founder and CEO of Aardvark Therapeutics, joined Judy Shaw on #NYSEFloorTalk to talk about their innovative obesity drug, ARD-101. He shared how it stands out from other treatments, the encouraging data so far, and what their upcoming trials will focus on. In the quest to tackle obesity, Aardvark Therapeutics is making waves […]
Nasdaq Listings Host Kristina Ayanian delves into companies’ notable accomplishments, industry trends, and the driving factors behind their success through engaging conversations with C-suite executives and industry leaders. Tien Lee, Founder and CEO of Aardvark Therapeutics, joins Nasdaq to celebrate our recent funding and discusses how our company specializes in gut brain interaction with a focus […]